Slc16a1 - OmicsDI

Show results for

Unknown (115)
Transcriptomics (40)
Genomics (25)
Proteomics (9)
Metabolomics (6)
Other (2)
Genomic (1)

Organisms

Mus musculus (19)
Homo sapiens (16)
Rattus norvegicus (6)
Andropogon gerardi (4)
Bacteria (4)
Canis lupus familiaris (4)
Chromatiales bacterium OalgGamma1 (4)
Clavibacter nebraskensis NCPPB 2581 (4)
Cnidaria (4)
Ensifer adhaerens (4)
Fasciola (4)
Human alphaherpesvirus 1 strain 17 (4)
Human alphaherpesvirus 1 strain KOS (4)
Human betaherpesvirus 5 (4)
Human herpesvirus 2 strain 186 (4)
Mesocricetus auratus (4)
Miscanthus x giganteus (4)
Mus musculus (4)
Panicum virgatum (4)
Platyhelminthes (4)
Pseudomonas aeruginosa PA103 (4)
Rattus norvegicus (4)
Bos taurus (2)
Sus scrofa (2)
Oryza sativa Indica Group (1)
Canis lupus familiaris (1)
Gallus gallus (1)
blank sample (1)
Cricetulus griseus (1)
Equus caballus (1)

Organisms

Mus musculus (8)
Homo sapiens (6)
Cricetulus griseus (1)
Equus caballus (1)
Rattus norvegicus (1)

Repository

biostudies-arrayexpress (26)
ENA (23)
geo (16)
MetaboLights (6)
jPOST (4)
pride (4)
EGA (2)
dbGaP (1)
iProX (1)

Tissue

Cell culture (2)
Epithelial cell (1)
Liver (1)
Lung (1)
Type B pancreatic cell (1)

Disease

Lung adenocarcinoma (1)
Lung squamous cell carcinoma (1)
Pancreatic cancer (1)

Technology Type

Mass spectrometry (4)
Mass Spectrometry (4)
Mass spectrometry assay (2)
Affinity purification coupled with mass spectrometry proteomics (1)
Gel-based experiment (1)
Shotgun proteomics (1)
Top-down proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - hilic (3)
Liquid Chromatography MS - positive - reverse phase (2)
Liquid Chromatography MS - positive - hilic (2)
Computer and Applied Biosystems 7500 Real Time PCR Systems thermal cycler (1)
GenePix 4000A [Axon Instruments] (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 4000 (1)
Liquid Chromatography MS - negative - direct infusion (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2023 (6)
2025 (6)
2024 (5)
2016 (4)
2015 (4)
2011 (4)
2010 (4)
2026 (4)
2012 (3)
2006 (3)
2022 (3)
2020 (2)
2018 (2)
2014 (2)
2017 (1)
2013 (1)
2009 (1)
2008 (1)
2021 (1)

CHEBI ID

CHEBI:15741 (2)
CHEBI:18012 (2)
CHEBI:30769 (2)
CHEBI:58262 (1)
CHEBI:193189 (1)
CHEBI:85442 (1)
CHEBI:64959 (1)
CHEBI:144355 (1)
CHEBI:16724 (1)
CHEBI:190340 (1)
CHEBI:16578 (1)
CHEBI:27466 (1)
CHEBI:15664 (1)
CHEBI:77366 (1)
CHEBI:177535 (1)
CHEBI:18425 (1)
CHEBI:18133 (1)
CHEBI:53488 (1)
CHEBI:15345 (1)
CHEBI:16493 (1)
CHEBI:48430 (1)
CHEBI:24848 (1)
CHEBI:17822 (1)
CHEBI:26271 (1)
CHEBI:15356 (1)
CHEBI:22660 (1)
CHEBI:18186 (1)
CHEBI:16811 (1)
CHEBI:28300 (1)
CHEBI:16708 (1)

Metabolite Name

3-hydroxy-3-methylglutaric acid (3)
Urocanate (2)
Thiamine monophosphate (2)
Salicylic acid .beta.-d-o-glucuronide (2)
Propanoic acid, 3-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]- (2)
Pi 36:2 (2)
Phenaceturic acid (2)
Pc(18:1e/14,15-eet) (2)
Nocardamine (2)
N-acetyl-d-galactosamine 4-sulfate (2)
L-Aspartate (2)
Glucoiberin (2)
DL-tryptophan (2)
Dehydro-l-(+)-ascorbic acid dimer (2)
D-myo-inositol-1,3-diphosphate (2)
Cytidine 3'-monophosphate (2)
Cyclohexanesulfamic acid (2)
Alpha-ketoisovaleric acid (2)
Adenosine 2'-monophosphate (2)
Acamprosate (2)
8z,14z-eicosadienoic acid (2)
4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (2)
3-hydroxykynurenine (2)
3-hydroxyglutaric acid (2)
2'-O-methylinosine (2)
2-chloro-2'-hydroxy-4'-methylbenzophenone (2)
1.alpha.-methyl-5.alpha.-androstan-3.alpha.,17.beta.-diol glucuronide (2)
1-(1z-octadecenyl)-2-(4z,7z,10z,13z,16z,19z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine (2)
[6]-gingerol (2)
(4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid (2)

First Public Date

2026 (5)
2024 (4)
2022 (3)
2016 (2)
2014 (2)
2013 (2)
2025 (1)
2023 (1)
2021 (1)
2020 (1)
2018 (1)

Study type

Transcription profiling by array (19)
Transcription profiling by RT-PCR (2)
RNA-seq of coding RNA (2)
Unknown experiment type (1)
Cell line - One-color microarray (1)
Methylation profiling by array (1)

Release Date

2020 (19)
2022 (19)
2024 (16)
2023 (13)
2025 (11)
2016 (8)
2015 (7)
2021 (6)
2019 (6)
2014 (5)
2010 (5)
2018 (4)
2011 (4)
2017 (3)
2013 (3)
2012 (3)
2026 (3)
2006 (2)
2007 (2)
2009 (1)
2008 (1)

Lab affiliation

Imperial College London and Université de Montréal (1)
Max Planck Institute of Biochemisrty (1)
Moffitt Cancer Center (1)
The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, USA (1)

Previous page
1 / 20
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 20
Next page

Sort by:

Relevance

Page size

Attenuate host susceptibility to respiratory virus invasion by inhibiting interactions between host proteins SLC16A3 and AP1G1

Modulating cell endocytosis activity to reduce host susceptibility to virus represents a promising strategy for antiviral drug development. In this study, we reveal that lactate transporter SLC16A3 as a critical host factor for reducing diverse virus invasion. By performing metabolomics, proteomi...

2025-07-28 | MTBLS12788 | MetaboLights

Oncogenic LncRNA SLC16A1-AS1 Cooperates with NSUN2 to Stabilize GRP78 mRNA via m5C Modification in Gastric Cancer

PRJNA1366474 | ENA

Oncogenic LncRNA SLC16A1-AS1 Cooperates with NSUN2 to Stabilize GRP78 mRNA via m5C Modification in Gastric Cancer [AGS]

PRJNA1368699 | ENA

Functional characterization of 5-oxoproline transport via SLC16A1/MCT1.

Not available

S-EPMC4303682 | biostudies-literature

Oncogenic LncRNA SLC16A1-AS1 Cooperates with NSUN2 to Stabilize GRP78 mRNA via m5C Modification in Gastric Cancer

Long noncoding RNAs (LncRNAs) play crucial roles in regulating chromatin dynamics and gene expression, and their dysregulation is closely linked to tumorigenesis. However, their specific functions in gastric cancer (GC) remain poorly understood. Here, we found that LncRNA SLC16A1-AS1 was markedly ov...

ORGANISM(S): Homo sapiens

2026-02-25 | GSE310529 | GEO

Exploring SLC16A1 as an Oncogenic Regulator and Therapeutic Target in Cholangiocarcinoma.

Not available

S-EPMC11190756 | biostudies-literature

Exosomal SLC16A1-AS1-induced M2 macrophages polarization facilitates hepatocellular carcinoma progression.

Not available

S-EPMC11379075 | biostudies-literature

Oncogenic LncRNA SLC16A1-AS1 Cooperates with NSUN2 to Stabilize GRP78 mRNA via m5C Modification in Gastric Cancer [AGS]

ORGANISM(S): Homo sapiens

2026-02-25 | GSE311114 | GEO

SLC16A1 Inhibits Ferroptosis and Promotes the Progression of Head and Neck Squamous Cell Carcinoma.